CureLab Veterinary
Early Stage
ElenaVet®’s p62 plasmid technology is poised to revolutionize cancer treatment in dogs and cats by upregulating the body's immune system and lowering inflammation.
Overview
Raised: $129,540
Total Commitments ($USD)
Platform
Netcapital
Start Date
12/21/2022
Close Date
05/20/2023
Min. Goal
$10,020
Max. Goal
$1,234,980
Min. Investment
$120
Security Type
Equity - Common
Series
Seed
SEC Filing Type
RegCF
Price Per Share
$30.00
Pre-Money Valuation
$32,653,950
Rolling Commitments ($USD)
Status
Funded
Reporting Date
05/30/2023
Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise
$869
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2020
Industry
Pet Health, Food, and Services
Tech Sector
Medtech
Distribution Model
B2C
Margin
Medium
Capital Intensity
High
CureLab Veterinary, with a valuation of $20 million, is raising funds on Netcapital. CureLab Veterinary product ElenaVet® is an anticancer/anti-inflammatory plasmid therapeutic that is poised to revolutionize cancer treatment in dogs and cats, extending the life of these family members. ElenaVet™ corrects the tumor microenvironment surrounding cancer cells, making it more favorable for anti-cancer immunity. Alex Shneider founded Curelab Veterinary in 2020. The current crowdfunding campaign has a minimum target of $ 10,020 and a maximum target of $1,234,980. The campaign proceeds will be used for compensation for managers, USDA consultant and regulatory, patent licensure and marketing.
Summary Profit and Loss Statement
| FY 2021 | FY 2020 | |
|---|---|---|
|
Revenue |
$0 |
$0 |
|
COGS |
$0 |
$0 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$-450 |
$-1,136 |
Summary Balance Sheet
| FY 2021 | FY 2020 | |
|---|---|---|
|
Cash |
$0 |
$0 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$0 |
$0 |
|
Short-Term Debt |
$252,544 |
$0 |
|
Long-Term Debt |
$0 |
$0 |
|
Total Liabilities |
$252,544 |
$0 |
Financials as of: 12/21/2022
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.
Ratings 
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.